Urmăriți
Z Ramtoola
Titlu
Citat de
Citat de
Anul
Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles
M Dunne, OI Corrigan, Z Ramtoola
Biomaterials 21 (16), 1659-1668, 2000
5592000
Binding and uptake of biodegradable poly-DL-lactide micro-and nanoparticles in intestinal epithelia
S McClean, E Prosser, E Meehan, D O'Malley, N Clarke, Z Ramtoola, ...
European Journal of Pharmaceutical Sciences 6 (2), 153-163, 1998
3371998
A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins
N Sivadas, D O’Rourke, A Tobin, V Buckley, Z Ramtoola, JG Kelly, ...
International journal of pharmaceutics 358 (1-2), 159-167, 2008
1292008
Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets
RM Pabari, Z Ramtoola
Journal of young pharmacists 4 (3), 157-163, 2012
1152012
Localised controlled release of simvastatin from porous chitosan–gelatin scaffolds engrafted with simvastatin loaded PLGA-microparticles for bone tissue engineering application
P Gentile, VK Nandagiri, J Daly, V Chiono, C Mattu, C Tonda-Turo, ...
Materials Science and Engineering: C 59, 249-257, 2016
1132016
Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating …
RM Pabari, Z Ramtoola
International journal of pharmaceutics 430 (1-2), 18-25, 2012
1102012
Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate
AA Raoof, P Chiu, Z Ramtoola, IK Cumming, C Teng, SP Weinbach, ...
Journal of pharmaceutical sciences 93 (6), 1431-1439, 2004
922004
Incorporation of PLGA nanoparticles into porous chitosan–gelatin scaffolds: Influence on the physical properties and cell behavior
VK Nandagiri, P Gentile, V Chiono, C Tonda-Turo, A Matsiko, Z Ramtoola, ...
Journal of the mechanical behavior of biomedical materials 4 (7), 1318-1327, 2011
882011
Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs
AA Raoof, Z Ramtoola, B McKenna, ZY Rosie, G Hardee, RS Geary
European journal of pharmaceutical sciences 17 (3), 131-138, 2002
792002
Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells
C Mattu, RM Pabari, M Boffito, S Sartori, G Ciardelli, Z Ramtoola
European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 463-472, 2013
702013
Investigation of the interaction of biodegradable micro-and nanoparticulate drug delivery systems with platelets
Z Ramtoola, P Lyons, K Keohane, SW Kerrigan, BP Kirby, JG Kelly
Journal of Pharmacy and Pharmacology 63 (1), 26-32, 2011
432011
Influence of parathyroid hormone-loaded PLGA nanoparticles in porous scaffolds for bone regeneration
P Gentile, VK Nandagiri, R Pabari, J Daly, C Tonda-Turo, G Ciardelli, ...
International Journal of Molecular Sciences 16 (9), 20492-20510, 2015
392015
Release kinetics of fluphenazine from biodegradable microspheres
Z Ramtoola, OI Corrigan, CJ Barrett
Journal of microencapsulation 9 (4), 415-423, 1992
391992
Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation
RM Pabari, C McDermott, J Barlow, Z Ramtoola
Clinical therapeutics 34 (11), 2221-2229, 2012
372012
Influence of Formulation Variables on the Morphology of Biodegradable Micropartieles Prepared by Spray Drying
N Clarke, K O'connor, Z Ramtoola
Drug development and industrial pharmacy 24 (2), 169-174, 1998
371998
Influence of the buffering capacity of the medium on the dissolution of drug-excipient mixtures
Z Ramtoola, OI Corrigan
Drug Development and Industrial Pharmacy 15 (14-16), 2359-2374, 1989
341989
Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions
R M Pabari, B Ryan, W Ahmad, Z Ramtoola
Current pharmaceutical biotechnology 14 (2), 220-225, 2013
332013
Intranasal and intravenous administration of octa-arginine modified poly (lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide
A O'Donnell, A Moollan, S Baneham, M Ozgul, RM Pabari, D Cox, ...
Journal of Pharmacy and Pharmacology 67 (4), 525-536, 2015
302015
Comparative evaluation of the degree of pegylation of poly (lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide
BP Kirby, R Pabari, CN Chen, M Al Baharna, J Walsh, Z Ramtoola
Journal of Pharmacy and Pharmacology 65 (10), 1473-1481, 2013
302013
Investigation of a novel 3-fluid nozzle spray drying technology for the engineering of multifunctional layered microparticles
RM Pabari, T Sunderland, Z Ramtoola
Expert opinion on drug delivery 9 (12), 1463-1474, 2012
302012
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20